Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.113
-0.027 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
1.110
-0.003 (-0.26%)
After-hours: Mar 6, 2026, 4:10 PM EST
Sunshine Biopharma Employees
Sunshine Biopharma had 52 employees as of December 31, 2024. The number of employees increased by 8 or 18.18% compared to the previous year.
Employees
52
Change (1Y)
8
Growth (1Y)
18.18%
Revenue / Employee
$717,764
Profits / Employee
-$115,243
Market Cap
5.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| China Pharma Holdings | 224 |
| IM Cannabis | 95 |
| Biofrontera | 93 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| InMed Pharmaceuticals | 13 |
| Shuttle Pharmaceuticals Holdings | 9 |
| Sonoma Pharmaceuticals | 8 |
SBFM News
- 4 months ago - Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) - Accesswire
- 4 months ago - Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea - Accesswire
- 4 months ago - Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline - Accesswire
- 5 months ago - Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin - Accesswire
- 5 months ago - Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM) - Accesswire
- 5 months ago - Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) - Accesswire
- 5 months ago - Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience - Accesswire
- 5 months ago - Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections - Accesswire